Буковинский Государственный Медицинский Университет Мз Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Буковинский Государственный Медицинский Университет Мз УкраиныfiledCriticalБуковинский Государственный Медицинский Университет Мз Украины
Priority to UAU201302736UpriorityCriticalpatent/UA82361U/en
Publication of UA82361UpublicationCriticalpatent/UA82361U/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
A method for correcting the altered plasma fibrinolysis in the patients with hypothyroidism comprises the standard etiolopathogenetic treatment. Escusan is used at a dose of 20 drops thrice a day for 15 days.
UAU201302736U2013-03-042013-03-04Method for correcting altered plasma fibrinolysis in patients with hypothyroidism
UA82361U
(en)